ConvaTec Group PLC (2CV.F)

3,0000 -0,0400 (-1,32%) Ab 09:13AM CEST. Markt geöffnet.

ConvaTec Group PLC

20 Eastbourne Terrace
7th Floor
London W2 6LG
United Kingdom

https://www.convatecgroup.com

Sektor(en): Healthcare
Branche: Medical Instruments & Supplies
Vollzeitmitarbeiter: 10.136

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Karim Bitar	CEO & Director	3,46M	N/A	1965
Mr. Jonathan Peter Mason	Group CFO & Director	1,85M	N/A	1964
Mr. John Haller	Executive VP and Chief Quality & Operations Officer	N/A	N/A	N/A
Dr. Divakar Ramakrishnan Ph.D.	Executive VP, Chief Technology Officer and Head of Research & Development	N/A	N/A	N/A
Ms. Kate Postans	Vice President of Investor Relations & Corporate Communications	N/A	N/A	N/A
Ms. Evelyn Douglas J.D.	Executive VP, Chief of Corporate Strategy & Business Development and General Counsel	N/A	N/A	N/A
Ms. Moyra Withycombe	Interim Chief People Officer	N/A	N/A	N/A
Ms. Kjersti Grimsrud Biotechnology, M.Sc.	President & COO of Infusion Care	N/A	N/A	1961
Mr. David Shepherd	President & COO of Global Advanced Wound Care	N/A	N/A	N/A
Mr. Seth R. Segel	President and COO of Continence Care & Home Services Group	N/A	N/A	1969

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Corporate Governance

ConvaTec Group PLCs ISS Governance QualityScore, Stand 1. Mai 2024, lautet 2. Die grundlegenden Scores sind Audit: 3, Vorstand: 3, Shareholderrechte: 1, Kompensation: 1.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.